Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Locoregional recurrence after neo-adjuvant chemotherapy (NACT) for early breast cancer: a literature review

Conference paper

Tyagi S. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 558 - 558

Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.

Journal article

Richards SH. et al, (2018), Eur J Prev Cardiol, 25, 247 - 259

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

Journal article

Hoyle M. et al, (2010), Value in Health, 13, 55 - 60

Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

Journal article

Hoyle M. et al, (2010), Value in Health, 13, 61 - 68

Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

Journal article

Thompson Coon JS. et al, (2010), British Journal of Cancer, 102, 234 - 235

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

Journal article

Connock M. et al, (2007), Health Technol Assess, 11, 1 - iv